Spectrascience Free Cash Flow Yield from 2010 to 2024

Spectrascience New's Free Cash Flow Yield is decreasing over the years with stable fluctuation. Free Cash Flow Yield is expected to dwindle to -1.54. Free Cash Flow Yield is a financial solvency ratio that compares the free cash flow per share Spectrascience New is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. View All Fundamentals
 
Free Cash Flow Yield  
First Reported
2010-12-31
Previous Quarter
(1.47)
Current Value
(1.54)
Quarterly Volatility
1.53245345
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Spectrascience New financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spectrascience New's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.4 M or Research Development of 937.2 K, as well as many indicators such as Price To Sales Ratio of 196, Days Sales Outstanding of 116 or Invested Capital of 0.0. Spectrascience financial statements analysis is a perfect complement when working with Spectrascience New Valuation or Volatility modules.
  
Check out the analysis of Spectrascience New Correlation against competitors.
For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Spectrascience New is a strong investment it is important to analyze Spectrascience New's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Spectrascience New's future performance. For an informed investment choice regarding Spectrascience Stock, refer to the following important reports:
Check out the analysis of Spectrascience New Correlation against competitors.
For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(0.92)
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.